Our results suggest that the functional importance of glutamine transport mediated by SLC1A5 in cancer cell proliferation and survival, and SLC1A5 in the glutamine metabolism pathway, is an important therapeutic target for lung cancer. The gene discussed is SLC1A5; the disease is lung cancer.